Contextualizing web-based decision support for endocrine therapy for breast cancer risk reduction: Usability and context insights in a cluster randomized trial

Despite the benefit of endocrine therapy (ET) for breast cancer risk reduction among high-risk women, uptake remains low. In the MiCHOICE trial, we evaluated the effectiveness of a patient decision support tool, RealRisks, compared to standard educational materials in improving informed choice among women with high-risk breast lesions. We found no significant difference in informed choice, but about half initiated ET. To better understand these outcomes, we conducted a qualitative study to explore factors influencing the effectiveness of this tool. We conducted interviews among patients and clinicians assigned to the intervention arm. Interviews were analyzed using the Technology Acceptance Model (TAM). Among 15 enrolled clinicians, 87% were female and 73% were breast surgeons or oncologists. Among 23 enrolled patients, median age was 49.7 years and 70% completed RealRisks. Patients and clinicians found RealRisks' multimodal presentation of risk to be useful, priming patients for the clinic visit and facilitating more productive conversations regarding ET. However, ease of use was limited by technological barriers and navigation challenges. Patients indicated that RealRisks reinforced clinic conversations rather than changing decisions. Despite positive patient and clinician attitudes toward RealRisks, targeted refinements to the decision aid are needed to translate perceived usefulness into measurable improvements in informed choice. The effectiveness of decision aids may depend not only on their content, but on timing and clinical context. Further studies should evaluate these tools among high-risk women identified in screening mammography or primary care, where impact may be greater.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2026-11-18
DOI
https://doi.org/10.1158/1940-6207.capr-26-0210
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Contextualizing web-based decision support for endocrine therapy for breast cancer risk reduction: Usability and context insights in a cluster randomized trial

Jason A. Zell, Masey Ross, Andrea Kaster, Banu Arun et al.
1 links
Cancer Prevention Research
Patient-Provider Communication in Healthcare
article

Contextualizing web-based decision support for endocrine therapy for breast cancer risk reduction: Usability and context insights in a cluster randomized trial

Jason A. Zell, Masey Ross, Andrea Kaster, Banu Arun, Cheryl L. Jernigan, Rita Kukafka, Claudia A DeYoung, Lisa D. Yee, Rachel Benish Shirley, Marian L. Neuhouser, Doreen Marie Agnese, Kari Braun Wisinski, Lindi H. Vanderwalde, Garnet L. Anderson, Debra A. Mangino, Sandhya Pruthi, Thomas James Saphner, Sarah Violet Colonna, Kathryn B. Arnold, Peter J. Zeiger, Stacy Krisher, Tarah Jean Ballinger, Kathleen J. Yost, Ana Cristina Sandoval-Leon, Anna Vaynrub, Shelly S. Lo, Tari A. King, Christa Braun‐Inglis, Katherine D. Crew, Vicky Ro, Alissa M. Michel, Corrine Zarwan, Maria Grosse Perdekamp, Dawn L. Hershman, Christina Hijiya, Julia D. Caci, Justin D. Floyd, Cathy Lynne Graham, Cynthia Law, Sam Dzingle, A. Conlin
article en

Abstract

Despite the benefit of endocrine therapy (ET) for breast cancer risk reduction among high-risk women, uptake remains low. In the MiCHOICE trial, we evaluated the effectiveness of a patient decision support tool, RealRisks, compared to standard educational materials in improving informed choice among women with high-risk breast lesions. We found no significant difference in informed choice, but about half initiated ET. To better understand these outcomes, we conducted a qualitative study to explore factors influencing the effectiveness of this tool. We conducted interviews among patients and clinicians assigned to the intervention arm. Interviews were analyzed using the Technology Acceptance Model (TAM). Among 15 enrolled clinicians, 87% were female and 73% were breast surgeons or oncologists. Among 23 enrolled patients, median age was 49.7 years and 70% completed RealRisks. Patients and clinicians found RealRisks' multimodal presentation of risk to be useful, priming patients for the clinic visit and facilitating more productive conversations regarding ET. However, ease of use was limited by technological barriers and navigation challenges. Patients indicated that RealRisks reinforced clinic conversations rather than changing decisions. Despite positive patient and clinician attitudes toward RealRisks, targeted refinements to the decision aid are needed to translate perceived usefulness into measurable improvements in informed choice. The effectiveness of decision aids may depend not only on their content, but on timing and clinical context. Further studies should evaluate these tools among high-risk women identified in screening mammography or primary care, where impact may be greater.

Cancer Prevention Research
Aurora Health Care (US), Indiana University Health (US), Lahey Hospital and Medical Center (US), City Of Hope National Medical Center (US), Sanford Health (US), Carle Foundation Hospital (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Mayo Clinic (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Wisconsin–Madison (US), Virginia Commonwealth University (US), Loyola University Chicago (US), University of California, Irvine (US), Cornell University (US), Columbia University Irving Medical Center (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), Huntsman Cancer Institute (US), Providence Portland Medical Center (US), Fred Hutch Cancer Center (US), Cancer Center of Hawaii (US), University of California, Irvine Medical Center (US), Baptist Health South Florida (US), Advanced Health Care of Aurora (US), Piedmont Cancer Institute (US), University of Wisconsin Carbone Cancer Center (US), Lahey Medical Center (US), Indiana Cancer Consortium (US), Baptist Memorial Health Care (US), City of Hope (US), Holy Redeemer (US), Cancer Care Specialists of Illinois (US), Kaiser Permanente Vallejo Medical Center (US), Butterworth Hospital (ZA), Corewell Health Butterworth Hospital (US), Samaritan Health Services (US), Indiana University Melvin and Bren Simon Comprehensive Cancer Center (US), University of Hawaii Cancer Center (US), Winship Cancer Institute (US), Weill Cornell Medical Center (US), Indiana University – Purdue University Indianapolis (US)
Good health and well-being
Patient-Provider Communication in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon